Ardigen
PrivateLast Round
Grant
Oct 25, 2021
Total Funding Raised
$7.9M
Momentum Score
25 /100
Company Overview
Ardigen is a biotechnology company that provides artificial intelligence-based bioinformatics technology intended to increase the probability of success in the drug development process.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ardigen Comps
Public and private peers based on sector, stage, and business model.
Ardigen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 25, 2021 | ||||
| Grant | Sep 23, 2020 | ||||
| Grant | Apr 27, 2020 | ||||
| Grant | Jan 1, 2018 |
Key People
Founding team and executive leadership
Ardigen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Centre for Research and Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 71% MoM, reaching 8.7K.
- Oct 28, 2024
Monthly visitors grew 108% MoM, reaching 15.2K.
Ardigen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ardigen's valuation, stock price, and market status.
